SLE 6000 & OxyGenie® China approval &250k Order

RNS Number : 0956W

Inspiration Healthcare Group PLC

21 April 2021

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

SLE 6000 and OxyGenie ® approved for sale in China

with confirmed orders of £250,000 for May 2021 delivery

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, is pleased to announce that SLE Ltd, the specialist neonatal ventilator manufacturer it acquired in July 2020, has received regulatory approval from the National Medical Products Administration (NMPA) to sell the enhanced version of the SLE6000 in China. The approval is for the top of the range SLE6000 model that includes various features such as enhanced High Frequency Oscillatory Ventilation, the OxyGenie ® patented oxygen control algorithm which helps maintain infants at their targeted oxygen saturation levels, volume targeted ventilation, End-Tidal CO₂ monitoring and greater non-invasive modes.

SLE Ltd has received an immediate order from its distributor in China worth approximately £250,000 for delivery during May 2021. 

Neil Campbell, Chief Executive Officer, commented:

"We are delighted that SLE has received approval for the SLE6000 in what is potentially one of our largest markets and also to announce that we have hit the ground running with a large order for immediate delivery. China represents a significant growth opportunity for the Group and we look forward to working with our partners and distributors to achieve our full potential there and in promoting our products and technology to achieve continued growth in the future."

Enquiries:

Inspiration Healthcare Group plc Neil Campbell, Chief Executive Officer Jon Ballard, Chief Financial Officer	Tel: [phone]
Nominated Adviser & Broker Cenkos Securities plc Mark Connelly Stephen Keys	Tel: [phone]
Cadogan PR  Alex Walters [e-mail]	Tel: [phone]

About Inspiration Healthcare Group

www.inspirationhealthcaregroup.plc.uk

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.

The Group currently consists of three companies: Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal intensive care and operating theatre equipment around the work through a network of distributors into over 75 countries.  Products range from highly sophisticated capital equipment through to single use disposables all that can help improve outcomes of extremely sick patients.

In the UK and Ireland the Group offers direct sales for most of its products supported by Technical Service offering on site and return to base repair and maintenance along with 24/7 emergency hire of equipment and long term lease arrangements for its own brand products.  The Group also acts as a distributor for 3^rd party companies that wish to access the NHS using the Group's sales and service expertise and knowledge of the NHS

The Group invests in growth through Research and Development holding numerous patents on its technology and has strong links with academic Key Opinion Leaders around the world and supports clinical research in the field of neonatal intensive care.

Further information on Inspiration Healthcare Group plc can be seen at  www.inspirationhealthcaregroup.plc.uk  

 

END

 

 

MSCMZGZDGGMGMZZ